Examkin

Question

Difficulty: MediumPharmacologic Interventions

A 45-year-old man with a history of alcohol use disorder and traumatic brain injury is brought to the emergency department with continuous generalized tonic-clonic convulsions. Paramedics report that the seizure began 20 minutes ago and has not ceased. His current medication list includes levetiracetam, which his family states he has not taken for a week, and a daily multivitamin.

Physical examination reveals a completely unresponsive patient with rhythmic, violent muscle contractions of all four extremities. Vital signs are temperature 37.8°C (100.0°F), blood pressure 150/90 mmHg, heart rate 130/min, and oxygen saturation 94% on a non-rebreather mask.

Pertinent laboratory findings:
Capillary blood glucose: 105 mg/dL
Serum sodium: 138 mEq/L
Serum calcium: 9.2 mg/dL

Arrange the following pharmacologic interventions in the correct algorithmic sequence for the progressive management of this patient's status epilepticus, starting with the initial first-line therapy and ending with the treatment for super-refractory disease.

  1. 1Intravenous lorazepam
  2. 2Intravenous fosphenytoin
  3. 3Intravenous propofol infusion
  4. 4Intravenous pentobarbital infusion

Answer

The correct sequence for managing status epilepticus is: 1) Intravenous lorazepam, 2) Intravenous fosphenytoin, 3) Intravenous propofol infusion, 4) Intravenous pentobarbital infusion.
The correct sequence for managing status epilepticus follows a strict time-based algorithm to balance rapid seizure termination with the prevention of respiratory and hemodynamic collapse. First-line therapy requires an immediate, rapid-acting benzodiazepine (intravenous lorazepam) to halt active convulsions. Once the active seizure is addressed, a second-line, longer-acting antiseizure medication (intravenous fosphenytoin) is administered to provide sustained seizure control. If seizures persist despite these interventions (refractory status epilepticus), the patient is escalated to third-line therapy with continuous anesthetic infusions (intravenous propofol), which necessitates endotracheal intubation. Finally, if the patient continues to seize despite anesthetic infusions (super-refractory status epilepticus), fourth-line therapy with a profound barbiturate coma (intravenous pentobarbital) is initiated.

Step-by-Step Solution

1
Identify the patient's condition as status epilepticus.
The patient has had continuous seizures for 20 minutes, necessitating immediate, algorithmic pharmacologic escalation.
Status epilepticus is a neurologic emergency with high morbidity and mortality if not treated promptly in a stepwise manner.
2
Select the appropriate first-line therapy.
Intravenous lorazepam is administered immediately.
Benzodiazepines quickly penetrate the blood-brain barrier to potentiate GABA-A receptors and halt active clinical seizures.
3
Determine the necessary second-line therapy for sustained control.
Intravenous fosphenytoin is administered next.
Once the initial seizure is addressed, a long-acting non-anesthetic antiseizure medication is required to prevent recurrence without causing profound respiratory depression.
4
Identify the treatment for refractory status epilepticus if seizures continue.
Intravenous propofol infusion is selected as third-line therapy.
When standard medications fail, continuous anesthetic infusions are initiated, which mandate endotracheal intubation and mechanical ventilation.
5
Determine the final escalation step for super-refractory cases.
Intravenous pentobarbital infusion is reserved as fourth-line therapy.
Barbiturate comas carry severe risks (e.g., profound hypotension, ileus) and are only used when other continuous anesthetics fail to achieve burst suppression on EEG.

Key Concept

Algorithmic stepwise pharmacologic escalation in status epilepticus, prioritizing rapid seizure termination followed by sustained control and continuous anesthetic coma for refractory cases.
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic